Portfolio Companies

Lund, Sweden, 08.00 CET, 20 February 2019 – BONESUPPORT HOLDING AB (publ) -listed on Nasdaq Stockholm - an emerging leader in Orthobiologics for the management of bone voi...
Read more

DUBLIN, Ireland and TREVOSE, Pa., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on ...
Read more

Stockholm —18 February 2019 — Oncopeptides AB (Nasdaq Stockholm, ONCO) today announces that the Company will release its Year-end Report on 22 February at 8:00 am CET. The r...
Read more

– Preliminary data from FIERCE-21 Phase 2 trial highlighted in oral presentation supports advancement to pivotal study – – Single agent activity and long-term treatment dura...
Read more

Thursday, February 14, 2019 Oslo, Norway, 14 February 2019 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-...
Read more

THU, FEB 14, 2019 07:30 CET OCT - DEC Net sales increased by 53% to SEK 62.2m (40.6). Adjusted for currency exchange rate effects, the increase was 44% Operating profit...
Read more

Mölndal, February 13, 2019 - Vicore Pharma Holding AB (publ) has decided to postpone the publication of the year-end report for 2018. The year-end report will be published on Marc...
Read more

Lund, Sweden, 08.00 CET, February 13, 2019 - BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids, today announces that the report for the thi...
Read more

Paris, France, February 12, 2019, 7:30 a.m. CET – GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and deve...
Read more

Monday, February 11, 2019 Trial extended in checkpoint inhibitor refractory melanoma with up to 12 additional patients receiving an increased dosing regimen ...
Read more